Ariad

3 Risks Ariad Investors Ought to Know About
Investopedia
Sat, 04/4/15 - 09:46 am
Ariad
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sun, 10/13/13 - 12:06 pm
Ariad
Acadia
Idenix
Ariad: Succumbing Temporarily To Extraordinary Pressure
Seeking Alpha
Sat, 08/10/13 - 12:07 pm
Ariad
Ariad's Potential Blockbuster Set for EU Debut
Motley Fool
Sat, 03/23/13 - 08:54 am
Ariad
Iclusig
chronic myeloid leukemia
5 Can't-Miss Health-Care Events This Week
Motley Fool
Sun, 02/24/13 - 02:29 pm
Onyx
Bayer
Zogenix
Ariad
Questcor
Medivation
3 Drug Launches You Need to Know in 2013
Motley Fool
Wed, 01/16/13 - 11:18 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
Iclusig
Ariad
chronic myeloid leukemia
Pfizer
Eliquis
Bristol-Myers Squibb
Maxim Group Highlights 3 Biotech Stocks With Key Milestones Ahead
Seeking Alpha
Sat, 08/25/12 - 11:35 am
Ariad
Exelixis
Medgenics
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Seeking Alpha
Fri, 01/27/12 - 11:08 am
Alexion
Amgen
Ariad
Biogen Idec
Bristol-Myers Squibb
Celgene
Gilead
Illumina
Inhibitex
Vertex Pharmaceuticals
7 Biotech Stocks Barclays Rates As Outperform
Seeking Alpha
Fri, 01/13/12 - 10:31 am
Celgene
Ziopharm
Jazz Pharmaceuticals
Vertex Pharmaceuticals
Ariad
Biogen Idec
Alexion
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Achillion
Aeterna Zentaris
Antigenics
Ariad
Amylin
Amarin
BioDelivery Sciences
Cyclacel
Geron
Dendreon
PharmAthene
Zalicus
Human Genome Sciences
Keryx
Peregrine Pharmaceuticals
SIGA technologies
YM BioSciences
Impressive Pipelines From Neoprobe and Ariad
Thu, 08/25/11 - 09:47 pm
pipelines
Neoprobe
Ariad